1 Non-LVP Parenterals Products Market Overview 1.1 Product Overview and Scope of Non-LVP Parenterals Products 1.2 Non-LVP Parenterals Products Segment by Type 1.2.1 Global Non-LVP Parenterals Products Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Ampules 1.2.3 Vials 1.2.4 Prefilled Syringes 1.3 Non-LVP Parenterals Products Segment by Application 1.3.1 Non-LVP Parenterals Products Sales Comparison by Application: (2021-2027) 1.3.2 Local Anesthetics 1.3.3 Vaccines 1.3.4 Other 1.4 Global Non-LVP Parenterals Products Market Size Estimates and Forecasts 1.4.1 Global Non-LVP Parenterals Products Revenue 2016-2027 1.4.2 Global Non-LVP Parenterals Products Sales 2016-2027 1.4.3 Non-LVP Parenterals Products Market Size by Region: 2016 Versus 2021 Versus 2027 2 Non-LVP Parenterals Products Market Competition by Manufacturers 2.1 Global Non-LVP Parenterals Products Sales Market Share by Manufacturers (2016-2021) 2.2 Global Non-LVP Parenterals Products Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Non-LVP Parenterals Products Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Non-LVP Parenterals Products Manufacturing Sites, Area Served, Product Type 2.5 Non-LVP Parenterals Products Market Competitive Situation and Trends 2.5.1 Non-LVP Parenterals Products Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Non-LVP Parenterals Products Players Market Share by Revenue 2.5.3 Global Non-LVP Parenterals Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Non-LVP Parenterals Products Retrospective Market Scenario by Region 3.1 Global Non-LVP Parenterals Products Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Non-LVP Parenterals Products Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Non-LVP Parenterals Products Market Facts & Figures by Country 3.3.1 North America Non-LVP Parenterals Products Sales by Country 3.3.2 North America Non-LVP Parenterals Products Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Non-LVP Parenterals Products Market Facts & Figures by Country 3.4.1 Europe Non-LVP Parenterals Products Sales by Country 3.4.2 Europe Non-LVP Parenterals Products Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Non-LVP Parenterals Products Market Facts & Figures by Region 3.5.1 Asia Pacific Non-LVP Parenterals Products Sales by Region 3.5.2 Asia Pacific Non-LVP Parenterals Products Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Non-LVP Parenterals Products Market Facts & Figures by Country 3.6.1 Latin America Non-LVP Parenterals Products Sales by Country 3.6.2 Latin America Non-LVP Parenterals Products Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Non-LVP Parenterals Products Market Facts & Figures by Country 3.7.1 Middle East and Africa Non-LVP Parenterals Products Sales by Country 3.7.2 Middle East and Africa Non-LVP Parenterals Products Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Non-LVP Parenterals Products Historic Market Analysis by Type 4.1 Global Non-LVP Parenterals Products Sales Market Share by Type (2016-2021) 4.2 Global Non-LVP Parenterals Products Revenue Market Share by Type (2016-2021) 4.3 Global Non-LVP Parenterals Products Price by Type (2016-2021) 5 Global Non-LVP Parenterals Products Historic Market Analysis by Application 5.1 Global Non-LVP Parenterals Products Sales Market Share by Application (2016-2021) 5.2 Global Non-LVP Parenterals Products Revenue Market Share by Application (2016-2021) 5.3 Global Non-LVP Parenterals Products Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Allergan 6.1.1 Allergan Corporation Information 6.1.2 Allergan Description and Business Overview 6.1.3 Allergan Non-LVP Parenterals Products Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Allergan Product Portfolio 6.1.5 Allergan Recent Developments/Updates 6.2 Bayer 6.2.1 Bayer Corporation Information 6.2.2 Bayer Description and Business Overview 6.2.3 Bayer Non-LVP Parenterals Products Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Bayer Product Portfolio 6.2.5 Bayer Recent Developments/Updates 6.3 GSK 6.3.1 GSK Corporation Information 6.3.2 GSK Description and Business Overview 6.3.3 GSK Non-LVP Parenterals Products Sales, Revenue and Gross Margin (2016-2021) 6.3.4 GSK Product Portfolio 6.3.5 GSK Recent Developments/Updates 6.4 J&J 6.4.1 J&J Corporation Information 6.4.2 J&J Description and Business Overview 6.4.3 J&J Non-LVP Parenterals Products Sales, Revenue and Gross Margin (2016-2021) 6.4.4 J&J Product Portfolio 6.4.5 J&J Recent Developments/Updates 6.5 Pfizer 6.5.1 Pfizer Corporation Information 6.5.2 Pfizer Description and Business Overview 6.5.3 Pfizer Non-LVP Parenterals Products Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Pfizer Product Portfolio 6.5.5 Pfizer Recent Developments/Updates 6.6 Teva 6.6.1 Teva Corporation Information 6.6.2 Teva Description and Business Overview 6.6.3 Teva Non-LVP Parenterals Products Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Teva Product Portfolio 6.6.5 Teva Recent Developments/Updates 6.7 Novartis 6.6.1 Novartis Corporation Information 6.6.2 Novartis Description and Business Overview 6.6.3 Novartis Non-LVP Parenterals Products Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Novartis Product Portfolio 6.7.5 Novartis Recent Developments/Updates 7 Non-LVP Parenterals Products Manufacturing Cost Analysis 7.1 Non-LVP Parenterals Products Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Non-LVP Parenterals Products 7.4 Non-LVP Parenterals Products Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Non-LVP Parenterals Products Distributors List 8.3 Non-LVP Parenterals Products Customers 9 Non-LVP Parenterals Products Market Dynamics 9.1 Non-LVP Parenterals Products Industry Trends 9.2 Non-LVP Parenterals Products Growth Drivers 9.3 Non-LVP Parenterals Products Market Challenges 9.4 Non-LVP Parenterals Products Market Restraints 10 Global Market Forecast 10.1 Non-LVP Parenterals Products Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Non-LVP Parenterals Products by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Non-LVP Parenterals Products by Type (2022-2027) 10.2 Non-LVP Parenterals Products Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Non-LVP Parenterals Products by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Non-LVP Parenterals Products by Application (2022-2027) 10.3 Non-LVP Parenterals Products Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Non-LVP Parenterals Products by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Non-LVP Parenterals Products by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Non-LVP Parenterals Products Sales (K Doses) Growth Rate Comparison by Type (2021-2027) Table 2. Global Non-LVP Parenterals Products Sales (K Doses) Comparison by Application (2021-2027) Table 3. Global Non-LVP Parenterals Products Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Non-LVP Parenterals Products Covered in This Study Table 5. Global Non-LVP Parenterals Products Sales (K Doses) of Key Manufacturers (2016-2021) Table 6. Global Non-LVP Parenterals Products Sales Share by Manufacturers (2016-2021) Table 7. Global Non-LVP Parenterals Products Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Non-LVP Parenterals Products Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Non-LVP Parenterals Products Average Price (USD/Dose) of Key Manufacturers (2016-2021) Table 10. Manufacturers Non-LVP Parenterals Products Manufacturing Sites and Area Served Table 11. Manufacturers Non-LVP Parenterals Products Product Type Table 12. Global Non-LVP Parenterals Products Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Non-LVP Parenterals Products by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-LVP Parenterals Products as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Non-LVP Parenterals Products Sales by Region (2016-2021) & (K Doses) Table 16. Global Non-LVP Parenterals Products Sales Market Share by Region (2016-2021) Table 17. Global Non-LVP Parenterals Products Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Non-LVP Parenterals Products Sales by Country (2016-2021) & (K Doses) Table 19. North America Non-LVP Parenterals Products Sales Market Share by Country (2016-2021) Table 20. North America Non-LVP Parenterals Products Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Non-LVP Parenterals Products Revenue Market Share by Country (2016-2021) Table 22. Europe Non-LVP Parenterals Products Sales by Country (2016-2021) & (K Doses) Table 23. Europe Non-LVP Parenterals Products Sales Market Share by Country (2016-2021) Table 24. Europe Non-LVP Parenterals Products Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Non-LVP Parenterals Products Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Non-LVP Parenterals Products Sales by Region (2016-2021) & (K Doses) Table 27. Asia Pacific Non-LVP Parenterals Products Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Non-LVP Parenterals Products Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Non-LVP Parenterals Products Revenue Market Share by Region (2016-2021) Table 30. Latin America Non-LVP Parenterals Products Sales by Country (2016-2021) & (K Doses) Table 31. Latin America Non-LVP Parenterals Products Sales Market Share by Country (2016-2021) Table 32. Latin America Non-LVP Parenterals Products Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Non-LVP Parenterals Products Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Non-LVP Parenterals Products Sales by Country (2016-2021) & (K Doses) Table 35. Middle East and Africa Non-LVP Parenterals Products Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Non-LVP Parenterals Products Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Non-LVP Parenterals Products Revenue Market Share by Country (2016-2021) Table 38. Global Non-LVP Parenterals Products Sales (K Doses) by Type (2016-2021) Table 39. Global Non-LVP Parenterals Products Sales Market Share by Type (2016-2021) Table 40. Global Non-LVP Parenterals Products Revenue (Million US$) by Type (2016-2021) Table 41. Global Non-LVP Parenterals Products Revenue Share by Type (2016-2021) Table 42. Global Non-LVP Parenterals Products Price (USD/Dose) by Type (2016-2021) Table 43. Global Non-LVP Parenterals Products Sales (K Doses) by Application (2016-2021) Table 44. Global Non-LVP Parenterals Products Sales Market Share by Application (2016-2021) Table 45. Global Non-LVP Parenterals Products Revenue (Million US$) by Application (2016-2021) Table 46. Global Non-LVP Parenterals Products Revenue Share by Application (2016-2021) Table 47. Global Non-LVP Parenterals Products Price (USD/Dose) by Application (2016-2021) Table 48. Allergan Corporation Information Table 49. Allergan Description and Business Overview Table 50. Allergan Non-LVP Parenterals Products Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021) Table 51. Allergan Non-LVP Parenterals Products Product Table 52. Allergan Recent Developments/Updates Table 53. Bayer Corporation Information Table 54. Bayer Description and Business Overview Table 55. Bayer Non-LVP Parenterals Products Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021) Table 56. Bayer Non-LVP Parenterals Products Product Table 57. Bayer Recent Developments/Updates Table 58. GSK Corporation Information Table 59. GSK Description and Business Overview Table 60. GSK Non-LVP Parenterals Products Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021) Table 61. GSK Non-LVP Parenterals Products Product Table 62. GSK Recent Developments/Updates Table 63. J&J Corporation Information Table 64. J&J Description and Business Overview Table 65. J&J Non-LVP Parenterals Products Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021) Table 66. J&J Non-LVP Parenterals Products Product Table 67. J&J Recent Developments/Updates Table 68. Pfizer Corporation Information Table 69. Pfizer Description and Business Overview Table 70. Pfizer Non-LVP Parenterals Products Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021) Table 71. Pfizer Non-LVP Parenterals Products Product Table 72. Pfizer Recent Developments/Updates Table 73. Teva Corporation Information Table 74. Teva Description and Business Overview Table 75. Teva Non-LVP Parenterals Products Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021) Table 76. Teva Non-LVP Parenterals Products Product Table 77. Teva Recent Developments/Updates Table 78. Novartis Corporation Information Table 79. Novartis Description and Business Overview Table 80. Novartis Non-LVP Parenterals Products Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021) Table 81. Novartis Non-LVP Parenterals Products Product Table 82. Novartis Recent Developments/Updates Table 83. Production Base and Market Concentration Rate of Raw Material Table 84. Key Suppliers of Raw Materials Table 85. Non-LVP Parenterals Products Distributors List Table 86. Non-LVP Parenterals Products Customers List Table 87. Non-LVP Parenterals Products Market Trends Table 88. Non-LVP Parenterals Products Growth Drivers Table 89. Non-LVP Parenterals Products Market Restraints Table 90. Global Non-LVP Parenterals Products Sales Forecast by Type (2022-2027) & (K Doses) Table 91. Global Non-LVP Parenterals Products Sales Market Share Forecast by Type (2022-2027) Table 92. Global Non-LVP Parenterals Products Revenue Forecast by Type (2022-2027) & (US$ Million) Table 93. Global Non-LVP Parenterals Products Revenue Market Share Forecast by Type (2022-2027) Table 94. Global Non-LVP Parenterals Products Sales Forecast by Application (2022-2027) & (K Doses) Table 95. Global Non-LVP Parenterals Products Sales Market Share Forecast by Application (2022-2027) Table 96. Global Non-LVP Parenterals Products Revenue Forecast by Application (2022-2027) & (US$ Million) Table 97. Global Non-LVP Parenterals Products Revenue Market Share Forecast by Application (2022-2027) Table 98. Global Non-LVP Parenterals Products Sales Forecast by Region (2022-2027) & (K Doses) Table 99. Global Non-LVP Parenterals Products Sales Market Share Forecast by Region (2022-2027) Table 100. Global Non-LVP Parenterals Products Revenue Forecast by Region (2022-2027) & (US$ Million) Table 101. Global Non-LVP Parenterals Products Revenue Market Share Forecast by Region (2022-2027) Table 102. Research Programs/Design for This Report Table 103. Key Data Information from Secondary Sources Table 104. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Non-LVP Parenterals Products Figure 2. Global Non-LVP Parenterals Products Market Share by Type in 2020 & 2027 Figure 3. Ampules Product Picture Figure 4. Vials Product Picture Figure 5. Prefilled Syringes Product Picture Figure 6. Global Non-LVP Parenterals Products Market Share by Application in 2020 & 2027 Figure 7. Local Anesthetics Figure 8. Vaccines Figure 9. Other Figure 10. Global Non-LVP Parenterals Products Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Non-LVP Parenterals Products Market Size 2016-2027 (US$ Million) Figure 12. Global Non-LVP Parenterals Products Sales 2016-2027 (K Doses) Figure 13. Global Non-LVP Parenterals Products Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 14. Non-LVP Parenterals Products Sales Share by Manufacturers in 2020 Figure 15. Global Non-LVP Parenterals Products Revenue Share by Manufacturers in 2020 Figure 16. The Global 5 and 10 Largest Non-LVP Parenterals Products Players: Market Share by Revenue in 2020 Figure 17. Non-LVP Parenterals Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 18. Global Non-LVP Parenterals Products Sales Market Share by Region (2016-2021) Figure 19. Global Non-LVP Parenterals Products Sales Market Share by Region in 2020 Figure 20. Global Non-LVP Parenterals Products Revenue Market Share by Region (2016-2021) Figure 21. Global Non-LVP Parenterals Products Revenue Market Share by Region in 2020 Figure 22. U.S. Non-LVP Parenterals Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Canada Non-LVP Parenterals Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Germany Non-LVP Parenterals Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. France Non-LVP Parenterals Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. U.K. Non-LVP Parenterals Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Italy Non-LVP Parenterals Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Russia Non-LVP Parenterals Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. China Non-LVP Parenterals Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Japan Non-LVP Parenterals Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. South Korea Non-LVP Parenterals Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. India Non-LVP Parenterals Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Australia Non-LVP Parenterals Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Taiwan Non-LVP Parenterals Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Indonesia Non-LVP Parenterals Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Thailand Non-LVP Parenterals Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Malaysia Non-LVP Parenterals Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Philippines Non-LVP Parenterals Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Vietnam Non-LVP Parenterals Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Mexico Non-LVP Parenterals Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Brazil Non-LVP Parenterals Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Argentina Non-LVP Parenterals Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Turkey Non-LVP Parenterals Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Saudi Arabia Non-LVP Parenterals Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. U.A.E Non-LVP Parenterals Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Sales Market Share of Non-LVP Parenterals Products by Type (2016-2021) Figure 47. Sales Market Share of Non-LVP Parenterals Products by Application (2016-2021) Figure 48. Sales Market Share of Non-LVP Parenterals Products by Application in 2020 Figure 49. Revenue Share of Non-LVP Parenterals Products by Application (2016-2021) Figure 50. Revenue Share of Non-LVP Parenterals Products by Application in 2020 Figure 51. Manufacturing Cost Structure of Non-LVP Parenterals Products Figure 52. Manufacturing Process Analysis of Non-LVP Parenterals Products Figure 53. Non-LVP Parenterals Products Industrial Chain Analysis Figure 54. Channels of Distribution Figure 55. Distributors Profiles Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Allergan Bayer GSK J&J Pfizer Teva Novartis